Word

NUVANIV

Status

Dead

Status Code

710

Status Date

Friday, June 4, 2021

Serial Number

86261843

Registration Number

4628814

Registration Date

Tuesday, October 28, 2014

Mark Type

4000

Filing Date

Thursday, April 24, 2014

Published for Opposition

Tuesday, August 12, 2014

Cancellation Date

Friday, June 4, 2021

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

The wording "NUVANIV" has no meaning in a foreign language.

Trademark Events

Jun 4, 2021

Cancelled Sec. 8 (6-Yr)

Oct 28, 2019

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Oct 28, 2014

Registered-Principal Register

Aug 12, 2014

Official Gazette Publication Confirmation E-Mailed

Aug 12, 2014

Published For Opposition

Jul 23, 2014

Notification Of Notice Of Publication E-Mailed

Jul 8, 2014

Law Office Publication Review Completed

Jun 23, 2014

Assigned To Lie

Jun 5, 2014

Approved For Pub - Principal Register

Jun 3, 2014

Examiner's Amendment Entered

Jun 3, 2014

Notification Of Examiners Amendment E-Mailed

Jun 3, 2014

Examiners Amendment E-Mailed

Jun 3, 2014

Examiners Amendment -Written

Jun 2, 2014

Assigned To Examiner

May 8, 2014

New Application Office Supplied Data Entered In Tram

Apr 28, 2014

New Application Entered In Tram